FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

4 results

ezetimibe and simvastatin
(Ezetimibe and Simvastatin)
AvKARE
Usage: Ezetimibe and simvastatin tablets are indicated as adjunct therapy to diet for reducing cholesterol and triglyceride levels in patients with primary or mixed hyperlipidemia, including homozygous familial hypercholesterolemia. They are part of a comprehensive approach to reduce the risk of atherosclerotic vascular disease.
nexlizet
(Bempedoic Acid and Ezetimibe)
Esperion Therapeutics, Inc.
Usage: NEXLIZET, a combination of bempedoic acid and ezetimibe, is indicated as an adjunct to diet for reducing LDL-C in adults with primary hyperlipidemia, including HeFH. Bempedoic acid also lowers myocardial infarction and coronary revascularization risk in adults unable to take statins, with or without established cardiovascular disease.
vytorin
(ezetimibe and simvastatin)
Organon LLC
Usage: VYTORIN is indicated as an adjunct to diet for reducing elevated LDL cholesterol in adults with primary hyperlipidemia and pediatric patients (10+ years) with heterozygous familial hypercholesterolemia. It also aids in reducing LDL in adults with homozygous familial hypercholesterolemia and lowers cardiovascular risks in high-risk adults.
zetia
(Ezetimibe)
Organon LLC
Usage: ZETIA® is indicated for reducing elevated LDL-C in adults with primary hyperlipidemia and HeFH, in pediatric patients (10+ years) with HeFH, adults with mixed hyperlipidemia, and those with HoFH. It also reduces sitosterol and campesterol levels in patients with homozygous familial sitosterolemia.

Dietary Cholesterol Absorption Inhibitor class drugs

ezetimibe and simvastatin

nexlizet

vytorin

zetia